E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/19/2005 in the Prospect News Bank Loan Daily, Prospect News Biotech Daily, Prospect News Distressed Debt Daily and Prospect News High Yield Daily.

S&P drops Del Laboratories view to negative

Standard & Poor's said it revised its outlook on Del Laboratories Inc. to negative from positive.

At the same time, the agency said it affirmed the company's B corporate credit and senior secured bank loan ratings and its CCC+ senior subordinated debt ratings.

The revised outlook reflects the company's weaker-than-expected operating performance in the first quarter of 2005 and S&P's expectations that the company will be challenged to fully achieve its planned cost savings and improve earnings in a challenging and mature market, the agency added.

The ratings reflect Del's high leverage as a result of its acquisition by Keslo & Co. in January, S&P said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.